Global Crohn’s Disease (CD) Treatment Market to reach US$ 17.80 billion by 2033; growing at a 4.3% CAGR: Future Market Insights, Inc. Study
22 mars 2023 09h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 22, 2023 (GLOBE NEWSWIRE) -- By the end of 2023, the worldwide Crohn's Disease (CD) Treatment Market is expected to be worth US$ 11.68 billion. According to Future Market...
OKYO Pharma Limited Prices $5.3 Million Offering of ADSs
13 mars 2023 16h15 HE
|
OKYO Pharma LTD
LONDON, March 13, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO, LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel...
OKYO Pharma to Present at the Second Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on February 21-23, 2023.
21 févr. 2023 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 21, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO) (“OKYO”, “OKYO Pharma” or the “Company”), an ophthalmology-focused bio-pharmaceutical company...
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
08 févr. 2023 09h00 HE
|
InSilico Medicine
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that...
Huntington’s Disease Treatment Market is expected to grow from USD 365 million in 2022 to USD 1,517 million by 2030 : GreyViews
06 févr. 2023 16h00 HE
|
GreyViews
Pune India, Feb. 06, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
Funding Renewed for Biotech Center, LSU One of Five Partners
06 déc. 2022 11h00 HE
|
LSU College of Engineering
BATON ROUGE, La., Dec. 06, 2022 (GLOBE NEWSWIRE) -- The Center for BioModular Multi-Scale Systems, or CBM2, was recently renewed for funding through the National Institutes of Health as a National...
RetinalGeniX Technologies, Inc. to Present at the Emerging Growth Conference Wednesday, October 26, 2022
24 oct. 2022 13h05 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX Technologies, Inc. OTCQB: RTGN to Present at the Emerging Growth Conference. RetinalGeniX Technologies, Inc. (RTGN) is pleased to...
Medical Device Packaging Market Size is projected to reach USD 61.27 Billion by 2030, growing at a CAGR of 8%: Straits Research
09 août 2022 09h20 HE
|
Straits Research
New York, United States, Aug. 09, 2022 (GLOBE NEWSWIRE) -- The primary function of healthcare packaging is to protect the products produced by the healthcare business. Healthcare items use packaging...
Vinay Mehindru, MD, MBA Appointed to RetinalGenix Technologies Inc. Board of Directors
26 juil. 2022 06h15 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- RetinalGenix™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today the appointment of Vinay Mehindru, MD, MBA to the...
RetinalGeniX Technologies, Inc. Acquires DNA/GPS Inc.
06 juil. 2022 08h00 HE
|
RetinalGeniX Technologies, Inc.
PETALUMA, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- RetinalGeniX™ Technologies, Inc. (OTCQB:RTGN) (“RetinalGeniX” or the “Company”), announced today the acquisition of DNA/GPS Inc.,...